Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Brian K Link |
| Publication date | August 1, 1998 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |